Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Estimate the effect of oral ketoconazole administration (400 mg once daily over 3 days) on
the pharmacokinetics (process by which the drug is absorbed, distributed, metabolized, and
eliminated by the body) of single 10 mg dose of tasocitinib (CP-690,550) in normal healthy
volunteers.